Pilbara Minerals (ASX: PLS) said it achieved a 'significant improvement in pricing outcomes' with major offtake customers, lifting its average spodumene price to approximately US$6,300/dmt.
The revised offtake pricing will apply for all shipments to the company's major offtake partners from December 2022 onwards.
To add some perspective, the average realised selling price in FY22 was US$2,382/dmt at production costs of approximately US$565/dmt (76.8% margins).
Market prices for spodumene was US$5,480/dmt, according to the company's FY22 results presentation.
On 29 June 2022, the Board approved the capital investment for the 'P680 Project' to boost the Pilgan Plant's annual production by 100,000 dmt to ~640,000 to 680,000 dmt.
The P680 Project was set to cost $297.5 million for larger crushing facility and rejection circuit. However, the increased cost of materials, equipment and quantities of work has bumped costs 35.9% higher to $404 million.
In parallel, the Board approved pre-FID (final investment decision) funding for the P1000 Expansion Project – set to increase annual spodumene production to up to 1 million tonnes per annum.
The $38.3 million pre-FID funding will support front-end engineering design and the procurement of long-lead equipment to support the delivery of P1000.
"The delivery of the P680 and P1000 expansion projects will cement Pilbara Minerals’ position as a major supplier of essential lithium raw materials required for the global energy transition," said CEO Dale Henderson.
On 16 December, Macquarie reaffirmed an OUTPERFORM rating for PLS with a $7.60 target price.
The analysts forecast FY23 adjusted profits to come in at $2.72 billion, up 385% from the $561.4 million in FY22. This will feed into a maiden dividend of 34 cents per share, which divided by the target price, assumes a dividend yield of 4.5%.
Get the latest news and insights direct to your inbox